L.M. Rapoport, E.A. Bezrukov, Ju.L. Demidko, A.V. Kondrashina Application of diferelin and its perspectives
The article presents a brief overview of luteinizing hormone-releasing hormone analogs in the treatment of prostate cancer. The authors report their experience with this drug class by an example of Diferelin. The experience with abiraterone in treatment of patients with hormonal resistance is described.